Bacteriophage Market: Current Analysis and Forecast (2022-2028)
Emphasis on Product Type (Pre-Biotic, Pre-Therapeutics), Application (Gastrointestinal track, Respiratory Infection Treatment, Urinary Tract Infections and Others) Route of Administration (Oral, Topical and Parenteral); and Region/Country
The Bacteriophage market was valued at USD 35.5 Bn and is expected to grow with a CAGR of 4.5% during the forecast period (2022-2028). The burgeoning demand for bacteriophage is attributed to the rising prevalence of foodborne diseases. Foodborne diseases are caused by the bacteria present in spoiled food. This is becoming more common. For instance, according to the health human Services 2019 report, around 1 in 6 people develops foodborne illness each year in the United States. Additionally, the strategies such as collaboration and partnership amongst the key players is further propelling the market growth for the bacteriophage. For instance, in 2019 Locus Bioscience a biotechnology company developing precision antibacterial therapies partnered with Janssen Pharmaceutical Companies of Johnson & Johnson, to develop, manufacture and commercialize CRISPR-Cas3-enhanced bacteriophage (“crPhage™”) products targeting two key bacterial pathogens for the potential treatment of infections of the respiratory tract and other organ systems. Thus these above-mentioned factors are anticipated to fuel the market growth in this region.
Some of the major players operating in the market include Armata Pharmaceuticals, Inc., Life Extension., Arthur Andrew Medical., Biochimpharm, Micreos, biostation., Probiotic America, LLC., Eliava BioPreparations, Locus Biosciences, Inc., BiomX
Insights Presented in the Report
“Amongst product type, the Pre-Therapeutic segment is growing with significant CAGR in 2021 market”
Based on product type, the market is bifurcated into pro-biotic and pre-therapeutics. Amongst these the pre-therapeutic segment is anticipated to grow with a significant CAGR during the forecasted period. Bacteriophages have been shown to be effective against antibiotic-resistant bacteria, and they have the potential to be used as a complementary therapy to antibiotics. By targeting specific bacteria, bacteriophages can help reduce the development of antibiotic resistance and improve treatment outcomes. Additionally, the increasing demand for preventive healthcare. With the rise of chronic diseases and an ageing population, there is a growing focus on preventing illnesses rather than just treating them once they occur. Further, bacteriophages have been shown to have the potential as a preventive treatment for bacterial infections, and this is expected to drive demand for pre-therapeutic products.
“Amongst applications, the gastrointestinal segment is growing with a significant CAGR in the market in 2021”
Based on the application, the market is segmented into the gastrointestinal tract, respiratory tract infection, urinary tract infections and others. Amongst these, the gastrointestinal segment is growing with a significant CAGR. The gastrointestinal tract is a common site for bacterial infections, and bacteriophages have been shown to be effective in treating and preventing these infections. Additionally, the growing awareness of the potential benefits of bacteriophages in treating gastrointestinal infections, as well as the increasing use of bacteriophages in the treatment of other bacterial infections, is anticipated to fuel the market growth of this segment.
“Amongst route of administration, the parenteral route segment is growing with a significant CAGR in the market in 2021”
Based on the end-users the market is segmented into oral, topical and parenteral. Amongst these, the parenteral route is anticipated to grow with a significant CAGR in the forecasted period. Certain antibiotics are metabolized by the liver before reaching the circulatory system, to prevent its metabolism these medications are administered parenterally. Additionally, the parenteral route has the ability to deliver the precise dose of medication rapidly. Further, these routes bypass the liver thus preventing its pre-metabolism. Thus, these above-mentioned elements are propelling the market growth of this segment.
“North America is anticipated to grow with significant CAGR of the bacteriophage market in 2021”
North America is anticipated to grow with a significant CAGR in the 2021 market. This is attributed towards the rising government initiative in this region. For instance, the assistant secretary for Planning and Evaluation 2020 report, launched a national action plan for combating the anti-biotic resistance bacteria 2020-2025, this plan presents coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance. Thus, North America is anticipated to grow with a significant CAGR in the forecasted period.
Bacteriophage Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global bacteriophage market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Bacteriophage Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global bacteriophage market were the three major steps undertaken to create and analyze the adoption of bacteriophages in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global bacteriophage market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the bacteriophage market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the bacteriophage market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product type, application and route of administration. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the bacteriophage market. Further, we conducted factor analysis using dependent and independent variables such as product type, application and route of administration of the bacteriophage market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the bacteriophage market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global bacteriophage market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the bacteriophage market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global bacteriophage market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global bacteriophage market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of disorder type, and service type in the global bacteriophage market.
The main objective of the Global Bacteriophage Market Study
The current & future market trends of the global bacteriophage market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the bacteriophage market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the disorder type and service type.
- Define and analysis of the regulatory framework for the bacteriophage industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the bacteriophage market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the bacteriophage market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
